Fayez Sarofim & CO Moderna, Inc. Transaction History

Fayez Sarofim & CO

  • $38.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$126.46 - $235.05 $132,783 - $246,802
-1,050 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$225.82 - $368.51 $169,365 - $276,382
-750 Reduced 41.67%
1,050 $267,000
Q1 2021

May 13, 2021
BUY
$109.18 - $185.98 $196,524 - $334,764
1,800 New
1,800 $236,000

Others Institutions Holding MRNA

# of Institutions
954
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Fayez Sarofim & CO Portfolio

Follow Fayez Sarofim & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email